213 related articles for article (PubMed ID: 18833294)
1. B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.
Forsell MN; Dey B; Mörner A; Svehla K; O'dell S; Högerkorp CM; Voss G; Thorstensson R; Shaw GM; Mascola JR; Karlsson Hedestam GB; Wyatt RT
PLoS Pathog; 2008 Oct; 4(10):e1000171. PubMed ID: 18833294
[TBL] [Abstract][Full Text] [Related]
2. Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primates.
Douagi I; Forsell MN; Sundling C; O'Dell S; Feng Y; Dosenovic P; Li Y; Seder R; Loré K; Mascola JR; Wyatt RT; Karlsson Hedestam GB
J Virol; 2010 Feb; 84(4):1683-95. PubMed ID: 19955308
[TBL] [Abstract][Full Text] [Related]
3. Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site.
Feng Y; McKee K; Tran K; O'Dell S; Schmidt SD; Phogat A; Forsell MN; Karlsson Hedestam GB; Mascola JR; Wyatt RT
J Biol Chem; 2012 Feb; 287(8):5673-86. PubMed ID: 22167180
[TBL] [Abstract][Full Text] [Related]
4. Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines.
Sharma VA; Kan E; Sun Y; Lian Y; Cisto J; Frasca V; Hilt S; Stamatatos L; Donnelly JJ; Ulmer JB; Barnett SW; Srivastava IK
Virology; 2006 Aug; 352(1):131-44. PubMed ID: 21894641
[TBL] [Abstract][Full Text] [Related]
5. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
[TBL] [Abstract][Full Text] [Related]
6. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region.
Wyatt R; Thali M; Tilley S; Pinter A; Posner M; Ho D; Robinson J; Sodroski J
J Virol; 1992 Dec; 66(12):6997-7004. PubMed ID: 1279195
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profile.
Forsell MN; McKee K; Feng Y; Mascola JR; Wyatt RT
AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1089-98. PubMed ID: 25245278
[TBL] [Abstract][Full Text] [Related]
8. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
9. CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies.
Madani N; Princiotto AM; Schön A; LaLonde J; Feng Y; Freire E; Park J; Courter JR; Jones DM; Robinson J; Liao HX; Moody MA; Permar S; Haynes B; Smith AB; Wyatt R; Sodroski J
J Virol; 2014 Jun; 88(12):6542-55. PubMed ID: 24696475
[TBL] [Abstract][Full Text] [Related]
10. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
[TBL] [Abstract][Full Text] [Related]
11. A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site.
Li L; Wang XH; Williams C; Volsky B; Steczko O; Seaman MS; Luthra K; Nyambi P; Nadas A; Giudicelli V; Lefranc MP; Zolla-Pazner S; Gorny MK
Mol Immunol; 2015 Aug; 66(2):364-74. PubMed ID: 25965315
[TBL] [Abstract][Full Text] [Related]
12. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies.
Xiang SH; Doka N; Choudhary RK; Sodroski J; Robinson JE
AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1207-17. PubMed ID: 12487827
[TBL] [Abstract][Full Text] [Related]
13. Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein.
Kassa A; Dey AK; Sarkar P; Labranche C; Go EP; Clark DF; Sun Y; Nandi A; Hartog K; Desaire H; Montefiori D; Carfi A; Srivastava IK; Barnett SW
PLoS One; 2013; 8(10):e76139. PubMed ID: 24146829
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human immunodeficiency virus type 1 monomeric and trimeric gp120 glycoproteins stabilized in the CD4-bound state: antigenicity, biophysics, and immunogenicity.
Dey B; Pancera M; Svehla K; Shu Y; Xiang SH; Vainshtein J; Li Y; Sodroski J; Kwong PD; Mascola JR; Wyatt R
J Virol; 2007 Jun; 81(11):5579-93. PubMed ID: 17360741
[TBL] [Abstract][Full Text] [Related]
15. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
17. A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates.
Pinter A; Honnen WJ; Racho ME; Tilley SA
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):985-96. PubMed ID: 7506556
[TBL] [Abstract][Full Text] [Related]
18. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
[TBL] [Abstract][Full Text] [Related]
19. Gp120/CD4 blocking antibodies are frequently elicited in ART-naïve chronically HIV-1 infected individuals.
Carrillo J; Molinos-Albert LM; Rodríguez de la Concepción ML; Marfil S; García E; Derking R; Sanders RW; Clotet B; Blanco J
PLoS One; 2015; 10(3):e0120648. PubMed ID: 25803681
[TBL] [Abstract][Full Text] [Related]
20. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
